Covid-19 and Immunity in Aging Populations — A New Research Agenda
Top Cited Papers
Open Access
- 27 August 2020
- journal article
- editorial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 383 (9), 804-805
- https://doi.org/10.1056/nejmp2006761
Abstract
The race is on throughout the world to develop Covid-19 vaccines and therapeutics and end a pandemic that threatens to infect a substantial portion of the planet’s population and perhaps kill millions of people, especially older adults. As billions of dollars flow into research and development efforts aimed at controlling the virus, the pandemic response remains hamstrung by our limited understanding of how to generate effective immunity, particularly in the elderly.Keywords
This publication has 4 references indexed in Scilit:
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19The New England Journal of Medicine, 2020
- Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?Trends in Immunology, 2020
- A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoringNature Medicine, 2019
- Personalized vaccinology: A reviewVaccine, 2018